Cargando…

The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial

BACKGROUND: Major depressive disorder is the second leading cause of years lost to disability worldwide. Anyu Peibo Capsule has been shown to be effective and safe in phase II trials. METHODS: This clinical study is a multi-center, randomized, double-blinded, placebo-controlled, parallel-group, phas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jingjing, Yu, Yimin, Jiang, Yi, Chen, Wu, Li, Yan, Shen, Yifeng, Zheng, Qingshan, Li, Huafang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414707/ https://www.ncbi.nlm.nih.gov/pubmed/34479619 http://dx.doi.org/10.1186/s13063-021-05550-9

Ejemplares similares

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults
por: He, Shen, et al.
Publicado: (2023)

Comparative Study on the Transcriptome of Maize Mature Embryos from Two China Elite Hybrids Zhengdan958 and Anyu5
por: Ma, Juan, et al.
Publicado: (2016)

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2021)

Promoter Hypomethylation of miR-124 Gene Is Associated With Major Depressive Disorder
por: Zeng, Duan, et al.
Publicado: (2021)

Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Dai, Liang, et al.
Publicado: (2016)

Analysis of Time-Course, Dose-Effect, and Influencing Factors of Antidepressants in the Treatment of Acute Adult Patients With Major Depression
por: Cheng, Qingqing, et al.
Publicado: (2019)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
por: Jørgensen, Caroline Kamp, et al.
Publicado: (2021)

Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
por: Siddiqui, Faiza, et al.
Publicado: (2021)

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022)

The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis
por: Jørgensen, Caroline Kamp, et al.
Publicado: (2023)

Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses
por: Juul, Sophie, et al.
Publicado: (2021)

The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Wang, Lexun, et al.
Publicado: (2021)

Efficacy of escitalopram monotherapy in the treatment of major depressive disorder: A pooled analysis of 4 Chinese clinical trials
por: Li, Guanjun, et al.
Publicado: (2017)

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
por: Zeng, Duan, et al.
Publicado: (2018)

Efficacy and safety of generic escitalopram versus Lexapro in the treatment of major depression: a multicenter double-blinded randomized controlled trial
por: Yu, Yimin, et al.
Publicado: (2013)

Origin and Genesis of Solid Bitumen from the Sinian Dengying Reservoir in the Deyang–Anyue Rift within the Sichuan Basin (SW China): Evidence from Biomarkers and Microscopic Features
por: Dai, Bokai, et al.
Publicado: (2021)

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
por: Liu, Haiyan, et al.
Publicado: (2022)

Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial
por: Wu, Rui, et al.
Publicado: (2020)

Efficacy and safety of Gyejibokryeong-hwan (GBH) in major depressive disorder: study protocol for multicentre randomised controlled trial
por: Choi, Yujin, et al.
Publicado: (2022)

Efficacy and Safety of tDCS and tACS in Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Factorial Placebo-Controlled Study Design
por: Huang, Yuxin, et al.
Publicado: (2021)

Adhesive capsulitis of the shoulder: protocol for the adhesive capsulitis biomarker (AdCaB) study
por: Page, Richard S., et al.
Publicado: (2019)

Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study
por: Chen, Yiyi, et al.
Publicado: (2019)

Co-Expression Network Analysis Revealed That the ATP5G1 Gene Is Associated With Major Depressive Disorder
por: Zeng, Duan, et al.
Publicado: (2019)

Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial
por: Green, Jessica E., et al.
Publicado: (2023)

N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial
por: Yang, Chenghao, et al.
Publicado: (2018)

Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial
por: Miravalles, Cerena, et al.
Publicado: (2022)

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020)

Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial
por: Huanjia, Gao, et al.
Publicado: (2021)

The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo design
por: Falkenberg, Irina, et al.
Publicado: (2023)

Effects of Chaihu-Shugan-San capsule for psychogenic erectile dysfunction: Study protocol of a randomized placebo-controlled trial
por: Ren, Feiqiang, et al.
Publicado: (2019)

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial
por: Zhou, Jingjing, et al.
Publicado: (2019)

Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol
por: Druart, Leo, et al.
Publicado: (2020)

Exercise for patients with major depression: a protocol for a systematic review with meta-analysis and trial sequential analysis
por: Krogh, Jesper, et al.
Publicado: (2015)

Characteristics and Spectrum of Cardiotoxicity Induced by Various Antipsychotics: A Real-World Study From 2015 to 2020 Based on FAERS
por: He, Luyao, et al.
Publicado: (2022)

Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial
por: Xiao, Mengli, et al.
Publicado: (2022)

A comprehensive regional neurochemical theory in depression: a protocol for the systematic review and meta-analysis of 1H-MRS studies in major depressive disorder
por: Drago, Thomas, et al.
Publicado: (2018)

Suicidal risk and executive functions in major depressive disorder: a study protocol
por: Roca, Miquel, et al.
Publicado: (2019)

Effectiveness and safety of low-level laser therapy in diabetic peripheral neuropathy: a protocol for a systematic review and meta-analysis
por: Lin, Lin, et al.
Publicado: (2021)

Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial
por: Giosan, Cezar, et al.
Publicado: (2017)

Efficacy of acupuncture on cognitive function in poststroke depression: study protocol for a randomized, placebo-controlled trial
por: Chen, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b7umgeu3bpr3eehjsr2a00j1vl